Hisamitsu Pharmaceutical Co., Inc. (TYO:4530)
Japan flag Japan · Delayed Price · Currency is JPY
4,025.00
-23.00 (-0.57%)
Jul 30, 2025, 3:30 PM JST

TYO:4530 Revenue

Hisamitsu Pharmaceutical Co. had revenue of 34.67B JPY in the quarter ending May 31, 2025, a decrease of -3.20%. This brings the company's revenue in the last twelve months to 154.86B, up 6.49% year-over-year. In the fiscal year ending February 28, 2025, Hisamitsu Pharmaceutical Co. had annual revenue of 156.01B with 10.09% growth.

Revenue (ttm)
154.86B
Revenue Growth
+6.49%
P/S Ratio
1.85
Revenue / Employee
55.33M
Employees
2,799
Market Cap
286.93B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Feb 28, 2025156.01B14.30B10.09%
Feb 29, 2024141.71B13.38B10.42%
Feb 28, 2023128.33B8.14B6.77%
Feb 28, 2022120.19B5.68B4.96%
Feb 28, 2021114.51B-26.48B-18.78%
Feb 29, 2020 Pro Pro Pro
Feb 28, 2019 Pro Pro Pro
Feb 28, 2018 Pro Pro Pro
Feb 28, 2017 Pro Pro Pro
Feb 29, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Chugai Pharmaceutical1,196.22B
Takeda Pharmaceutical Company4,581.55B
Daiichi Sankyo Company1,886.26B
HOYA Corporation866.03B
Terumo1,036.17B
Otsuka Holdings2,393.18B
Astellas Pharma1,912.32B
Shionogi &438.27B
Revenue Rankings